Site
Search results (7 results)
-
References | 2 Apr 2014
Fingolimod Therapy in Early Multiple Sclerosis: An Efficacy Analysis of the TRANSFORMS and FREEDOMS Studies by Time Since First Symptom.
-
References | 30 Dec 2014
Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMS.
Meng X, Chin PS, Hashmonay R, Zahur Islam M, Cutter GContemp Clin Trials. 2014 Dec 26. PMID: 25545026. Abstract -
References | 28 Jul 2016
Relapse rates in patients with multiple sclerosis treated with fingolimod: Subgroup analyses of pooled data from three phase 3 trials.
Derfuss T, Ontaneda D, Nicholas J, Meng X, Hawker KMult Scler Relat Disord. 2016 Jul; 8:124-30. Epub 2016 May 24. PMID: 27456887. Abstract -
References | 23 Sep 2014
Efficacy and Safety of Fingolimod in Hispanic Patients with Multiple Sclerosis: Pooled Clinical Trial Analyses.
Chinea Martinez AR, Correale J, Coyle PK, Meng X, Tenenbaum NAdv Ther. 2014 Sep 23. Epub 2014 Sep 23. PMID: 25245812. Abstract -
References | 8 Sep 2015
Disease Activity during the First Year Predicts Clinical Long-Term Outcomes in Patients with Multiple Sclerosis: Fingolimod Treatment Benefit
Repovic P, Burton E, Meng X, Meier D P, Barkhof F, Consortium of Multiple Sclerosis Centers Annual Meeting Presentations, 29 May 2015Accessed on 8 Sep 2015 from https://cmsc.confex.com/cmsc/2015/webprogram/. -
References | 5 Nov 2013
Impact of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod: Subgroup analyses of the Fingolimod Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) study.
Kremenchutzky M, O'Connor P, Hohlfeld R, Zhang-Auberson L, von Rosenstiel P, Meng X, Grinspan A, Hashmonay R, Kappos LMult Scler Relat Disord. 2014 May; 3(3):341-9. Epub 2013 Nov 05. PMID: 25876471. Abstract -
References | 22 Mar 2016
Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial.
Hunter SF, Agius M, Miller DM, Cutter G, Barbato L, McCague K, Meng X, Agashivala N, Chin P, Hollander EJ Neurol Sci. 2016 Jun 15; 365:190-8. Epub 2016 Mar 22. PMID: 27206905. Abstract